IMIDomics
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $17M
Investors
- 4
About IMIDomics
Based in Spain, IMIDomics Inc.Founded in 2015 and headquartered in Barcelona, Spain, IMIDomics Inc. focuses on innovative treatments for a range of IMIDs.IMIDomics specializes in the development of first-in-class medicines aimed at treating immune-mediated inflammatory diseases (IMIDs) such as Systemic Lupus Erythematosus, Ulcerative Colitis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Atopic Dermatitis, and Sjögren’s Syndrome. The company’s innovative pipeline is supported by a proprietary database comprising over 17 years of clinical and biomolecular data, which aids in identifying the most suitable patient populations for each therapeutic candidate. IMIDomics focuses on creating targeted therapies that specifically address the needs of patients who do not adequately respond to existing treatments, thereby enhancing the effectiveness of care.IMIDomics generates revenue primarily through partnerships and collaborations in the pharmaceutical industry. The company engages in B2B transactions with pharmaceutical companies and healthcare providers, providing access to its extensive biobanking and data analytics capabilities. Revenue streams are derived from licensing agreements for its proprietary drug candidates and services related to patient data analysis. Through these collaborations, clients benefit from tailored therapeutics aimed at specific patient demographics, which allows for a more effective treatment regimen. The company aims to expand its operations further into the US and European markets, focusing on the development of new therapeutic candidates for IMIDs.
Who invested in IMIDomics
4 investors across 1 round
See all investors in IMIDomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 27, 2021
Amount
$17M
Investors
Questions about IMIDomics
Who invested in IMIDomics?
IMIDomics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IMIDomics raised?
IMIDomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IMIDomics last raise money?
IMIDomics's most recent round on record is a Series A, in Jul 2021.
What does IMIDomics do?
IMIDomics is a biotechnology company.
Where is IMIDomics headquartered?
IMIDomics is headquartered in Barcelona, Spain.
Which VCs invest in companies like IMIDomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at IMIDomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like IMIDomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.